Clinical Trial Update: Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on an ongoing Phase 1/2 study (STEP) evaluating the safety, tolerability, and exploratory efficacy of EC5026 in Parkinson's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• EC5026

Snippet

Sponsor: EicOsis Human Health Inc. | Conditions: Parkinson's Disease (PD) | Phase 1, Phase 2 | Status: RECRUITING